Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › hCG

hCG

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of hCG

8 trials tracked of hCG: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 45 citations.

8Trials tracked
5Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 3 Other / NA 3
  1. Phase 3 A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) Completed · 45 cited
  2. Phase 4 Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS Completed · 8 cited
  3. Phase 4 Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome Completed
  4. Phase 3 Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043) Completed
  5. Phase 3 A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787) Completed
  6. N/A Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS) Completed
Show 2 more trials
  1. N/A Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716) Completed
  2. N/A Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712) Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Therapeutic LH window of 1 to 10 IU/L supports optimal follicular development in IVF patients
Diabetes & Endocrinology Sys. Review
Therapeutic LH window of 1 to 10 IU/L supports optimal follicular development in IVF patients Finding the right hormone levels for successful IVF pregnancies
This narrative review synthesizes literature from 1985 to 2025 regarding the impact of LH levels on ovarian stimulation for normogonadotropi…
New research identifies a specific window of LH hormone levels that may help improve follicle growth and pregnancy success in IVF treatments…
Frontiers Aug 18, 2026
Network meta-analysis finds GnRHa trigger reduces OHSS risk versus hCG in predicted high responders undergoing IVF
Diabetes & Endocrinology Meta-analysis
Network meta-analysis finds GnRHa trigger reduces OHSS risk versus hCG in predicted high responders undergoing IVF Study compares four IVF trigger methods for women at high risk of over-response
A network meta-analysis of 7 RCTs involving 632 predicted high responders undergoing IVF with GnRH antagonist protocols compared four final …
For women at high risk of painful IVF complications, a specific hormone trigger shot significantly lowers that risk without reducing egg cou…
Frontiers Apr 8, 2026
Triple therapy for CHH shows lower hCG dose but similar spermatogenesis rates in small RCT
Diabetes & Endocrinology RCT
Triple therapy for CHH shows lower hCG dose but similar spermatogenesis rates in small RCT Can a triple-hormone approach help men with a rare fertility condition?
A randomized trial in 45 adult males with congenital hypogonadotropic hypogonadism compared triple therapy (hCG, FSH, testosterone) to combi…
Men with a rare fertility condition using three hormones together needed lower weekly doses of one drug and reported better quality of life …
Frontiers Apr 8, 2026